New York, NY, United States of America

Gregory R Moe

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: University Patents, Inc.. Active years: 1985-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory R Moe. Retrieved from https://idiyas.com/inventor/gregory-r-moe-oityh76x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1985-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gregory R Moe: Innovator in Peptide Hormones

Introduction

Gregory R Moe is a distinguished inventor based in New York, NY (US). He has made significant contributions to the field of peptide hormones, holding a total of 2 patents. His work focuses on novel peptide hormones with calcitonin-like activity, showcasing his expertise in biochemistry and molecular biology.

Latest Patents

Moe's latest patents include innovative compounds that exhibit calcitonin-like activity. These patents detail peptide hormones with specific structural formulas, emphasizing the importance of amino acid moieties in their functionality. His research has the potential to impact various therapeutic applications, particularly in the realm of hormonal treatments.

Career Highlights

Gregory R Moe is affiliated with University Patents, Inc., where he continues to advance his research and development efforts. His academic background and professional experience have positioned him as a key figure in the innovation of peptide-based therapies.

Collaborations

Moe collaborates with Emil T Kaiser, further enhancing the scope and impact of his research. Their partnership exemplifies the collaborative nature of scientific innovation, where shared expertise leads to groundbreaking discoveries.

Conclusion

Gregory R Moe's contributions to the field of peptide hormones are noteworthy, with his patents reflecting a commitment to advancing medical science. His work continues to inspire future innovations in hormonal therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…